These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 18188568

  • 1. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J, Nevozhay D, Milczarek M, Filip B, Kutner A.
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [Abstract] [Full Text] [Related]

  • 2. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J, Pełczyńska M, Madej J, Dzimira S, Kuśnierczyk H, Kutner A, Szelejewski W, Opolski A.
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [Abstract] [Full Text] [Related]

  • 3. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J, Nevozhay D, Filip B, Milczarek M, Kutner A.
    Anticancer Res; 2007 Sep; 27(5A):3387-98. PubMed ID: 17970085
    [Abstract] [Full Text] [Related]

  • 4. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 5. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
    Wietrzyk J, Milczarek M, Kutner A.
    Oncol Res; 2007 Aug 01; 16(11):517-25. PubMed ID: 18306931
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
    Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA.
    Oncology; 2006 Aug 01; 70(6):483-92. PubMed ID: 17237623
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
    Milczarek M, Filip-Psurska B, Swiętnicki W, Kutner A, Wietrzyk J.
    Oncol Rep; 2014 Aug 01; 32(2):491-504. PubMed ID: 24919507
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines.
    Wietrzyk J, Filip B, Milczarek M, Klopotowska D, Maciejewska M, Dabrowska K, Kurzepa A, Dzimira S, Madej J, Kutner A.
    Oncol Rep; 2008 Oct 01; 20(4):941-52. PubMed ID: 18813838
    [Abstract] [Full Text] [Related]

  • 13. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
    Pelczynska M, Wietrzyk J, Jaroszewicz I, Nevozhay D, Switalska M, Kutner A, Zabel M, Opolski A.
    Anticancer Res; 2005 Oct 01; 25(3B):2235-40. PubMed ID: 16158969
    [Abstract] [Full Text] [Related]

  • 14. Effects of PRI-2191--a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat.
    Tetich M, Dziedzicka-Wasylewska M, Kuśmider M, Kutner A, Leśkiewicz M, Jaworska-Feil L, Budziszewska B, Kubera M, Myint AM, Basta-Kaim A, Skowroński M, Lasoń W.
    Brain Res; 2005 Mar 28; 1039(1-2):1-13. PubMed ID: 15781040
    [Abstract] [Full Text] [Related]

  • 15. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, Bandyopadhyay A, Knight V, Gilbert BE, Sanders BG, Kline K.
    Cancer Chemother Pharmacol; 2004 Nov 28; 54(5):421-31. PubMed ID: 15197487
    [Abstract] [Full Text] [Related]

  • 16. Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis.
    Kensler TW, Dolan PM, Gange SJ, Lee JK, Wang Q, Posner GH.
    Carcinogenesis; 2000 Jul 28; 21(7):1341-5. PubMed ID: 10874012
    [Abstract] [Full Text] [Related]

  • 17. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
    Yin Y, Ni J, Chen M, Guo Y, Yeh S.
    Clin Cancer Res; 2009 Jan 01; 15(1):190-200. PubMed ID: 19118046
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
    Pelczynska M, Switalska M, Maciejewska M, Jaroszewicz I, Kutner A, Opolski A.
    Anticancer Res; 2006 Jan 01; 26(4A):2701-5. PubMed ID: 16886680
    [Abstract] [Full Text] [Related]

  • 19. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C, Radeke HH, Sartory NA, Zahn N, Zuegel U, Steinmeyer A, Stein J.
    J Pharmacol Exp Ther; 2006 Nov 01; 319(2):622-31. PubMed ID: 16914561
    [Abstract] [Full Text] [Related]

  • 20. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
    Zinser GM, Tribble E, Valrance M, Urben CM, Knutson JC, Mazess RB, Strugnell SA, Welsh J.
    Anticancer Res; 2005 Nov 01; 25(1A):235-41. PubMed ID: 15816543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.